AFM
AZN icon

Armstrong Fleming & Moore’s AstraZeneca AZN Stock Holding History

Armstrong Fleming & Moore’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Hold
1,383
– – 0.12% 88
2025
Q4 		$254K Hold
1,383
– – 0.12% 87
2025
Q3 		$212K Buy
+1,383
New +$209K 0.1% 106
2024
Q4 		– Sell
-1,372
Closed -$214K – 96
2024
Q3 		$214K Buy
1,372
+3
+0.2% +$484 0.12% 95
2024
Q2 		$213K Buy
+1,369
New +$206K 0.14% 89

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Armstrong Fleming & Moore's AZN Position: Q1 2026 in Review

Armstrong Fleming & Moore held its AstraZeneca (AZN) position steady in Q1 2026 at 1,383 shares worth $273K. The position accounts for 0.12% of the portfolio, ranked #88.

Armstrong Fleming & Moore first reported a position in AZN in Q2 2024 and has held it in 5 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Armstrong Fleming & Moore held 1,383 shares of AstraZeneca worth $273K as of Q1 2026.
  • Armstrong Fleming & Moore left its AstraZeneca share count unchanged in Q1 2026.
  • AstraZeneca made up 0.12% of Armstrong Fleming & Moore's portfolio in Q1 2026, its #88 holding.
  • Armstrong Fleming & Moore first reported a position in AstraZeneca in Q2 2024 and has held it in 5 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Armstrong Fleming & Moore's 13F filing for Q1 2026, filed 13 Apr 2026.